InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Tuesday, 10/24/2017 4:51:55 PM

Tuesday, October 24, 2017 4:51:55 PM

Post# of 48316
Appears that this latest stock offering was handled by Wainwright, Oppenheimer was terminated, but not before they sold nearly 1 million shares for Oncosec.

Effective as of October 22, 2017, the Company terminated the equity distribution agreement (the “Distribution Agreement”), dated July 25, 2017, by and between the Company and Oppenheimer & Co. Inc. (“Oppenheimer”). The Distribution Agreement permitted the Company to offer and sell, by any method deemed to be an “at the market offering” as defined in Rule 415 promulgated under the Securities Act and from time to time through or to Oppenheimer, acting as sales agent or principal, shares of its common stock having an aggregate gross sales price as specified in the most recent prospectus supplement filed with the Commission relating to such shares. As a result of the termination of the Distribution Agreement, no further offers or sales of shares of the Company’s common stock will be made thereunder. As of the date of this Current Report on Form 8-K, the Company has sold an aggregate of 897,311 shares of its common stock pursuant to the Distribution Agreement, for gross proceeds of $1,125,626 and net proceeds, after deducting Oppenheimer’s commissions and other expenses paid or payable by the Company, of $1,097,459.

so Oncosec netted around $7 million if you include another $1 million from Oppenheimer. I sure hope this is the last dilution before a licensing deal is struck.

This was actually a new stock offering, not the ATM agreement with Oppenheimer. Wondering why the shift in the offering all of a sudden. Must have had sudden interest from certain institutions....hopefully not just SABBY

NOTICED ALOT OF BUYING AT 1.05 AT THE END OF TODAY.